Nuveen LLC Acquires New Stake in American Healthcare REIT, Inc. (NYSE:AHR)

Key Points

• Nuveen LLC has acquired a new stake in American Healthcare REIT, Inc., purchasing 2,247,439 shares valued at approximately $68 million, reflecting a ownership of about 1.43% as of their latest filing.
• American Healthcare REIT reported earnings of $0.42 per share for the quarter, which surpassed analysts' expectations of $0.40, alongside a revenue increase of 7.5% year-over-year.
• The company recently announced a quarterly dividend of $0.25 per share, equating to an annual yield of 2.5%, although it has a negative payout ratio of -454.55%.

Nuveen LLC purchased a new position in American Healthcare REIT, Inc. (NYSE:AHR - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 2,247,439 shares of the company's stock, valued at approximately $68,097,000. Nuveen LLC owned about 1.43% of American Healthcare REIT as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. Wolff Wiese Magana LLC acquired a new position in American Healthcare REIT in the first quarter worth approximately $25,000. MassMutual Private Wealth & Trust FSB grew its position in American Healthcare REIT by 189.0% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 968 shares of the company's stock worth $29,000 after buying an additional 633 shares during the last quarter. Spirit of America Management Corp NY acquired a new position in American Healthcare REIT in the first quarter worth approximately $30,000. Avalon Trust Co acquired a new position in American Healthcare REIT in the first quarter worth approximately $36,000. Finally, Continuum Advisory LLC acquired a new position in American Healthcare REIT in the first quarter worth approximately $37,000. Institutional investors and hedge funds own 16.68% of the company's stock.

American Healthcare REIT Trading Up 0.3%

Shares of NYSE:AHR opened at $40.67 on Thursday. The firm has a fifty day moving average of $37.22 and a two-hundred day moving average of $32.91. The firm has a market capitalization of $6.49 billion, a P/E ratio of -184.86, a price-to-earnings-growth ratio of 2.25 and a beta of 1.08. American Healthcare REIT, Inc. has a 12-month low of $17.62 and a 12-month high of $41.50. The company has a quick ratio of 0.38, a current ratio of 0.48 and a debt-to-equity ratio of 0.41.

American Healthcare REIT (NYSE:AHR - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported $0.42 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.02. The company had revenue of $542.50 million during the quarter, compared to analyst estimates of $539.49 million. American Healthcare REIT had a negative net margin of 1.56% and a negative return on equity of 1.43%. The company's revenue for the quarter was up 7.5% on a year-over-year basis. During the same quarter last year, the business posted $0.33 EPS. On average, equities analysts expect that American Healthcare REIT, Inc. will post 1.41 EPS for the current fiscal year.

American Healthcare REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 18th. Investors of record on Monday, June 30th were paid a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, June 30th. American Healthcare REIT's payout ratio is presently -454.55%.

Insider Activity

In related news, CIO Stefan K.L. Oh sold 3,860 shares of American Healthcare REIT stock in a transaction on Monday, June 30th. The shares were sold at an average price of $36.10, for a total value of $139,346.00. Following the completion of the sale, the executive owned 95,671 shares of the company's stock, valued at approximately $3,453,723.10. The trade was a 3.88% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.92% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on AHR shares. Jefferies Financial Group started coverage on shares of American Healthcare REIT in a research report on Monday, April 28th. They issued a "buy" rating and a $37.00 price target on the stock. Baird R W raised shares of American Healthcare REIT to a "strong-buy" rating in a research note on Thursday, July 17th. Robert W. Baird assumed coverage on shares of American Healthcare REIT in a research note on Friday, July 18th. They issued an "outperform" rating and a $41.00 price objective for the company. KeyCorp raised their price objective on shares of American Healthcare REIT from $34.00 to $40.00 and gave the stock an "overweight" rating in a research note on Wednesday, June 11th. Finally, JMP Securities raised their price objective on shares of American Healthcare REIT from $40.00 to $45.00 and gave the stock a "market outperform" rating in a research note on Monday. Ten investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, American Healthcare REIT currently has a consensus rating of "Buy" and an average price target of $40.44.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.